Through a project to reduce gaps and inequities in lupus care and treatment, ACR work groups have developed five quality measures focused on clinical and patient-reported outcomes and are integrating them into the RISE registry to support patient care and research.
The field of rheumatology is leading the way in the Centers for Medicare and Medicaid Services’ new MIPS Value Pathways with rheumatology-specific quality measures and improvement activities.
A panel of rheumatologists will provide updates on MACRA’s quality measure requirements and the ACR’s progress in quality measurement in rheumatology in a session at ACR Convergence 2020.
The ACR has highlighted critical changes for the 2021 performance year outlined in the proposed rule released Aug. 3 by the Centers for Medicare & Medicaid Services.
With electronic clinical quality measures tailored for treating gout patients, physicians and their teams now have tools to measure and improve gout care performance and outcomes…
In 2008, the only Physician Quality Reporting Initiative (PQRI) measure that applied to rheumatoid arthritis (RA) was disease-modifying antirheumatic drug therapy. For 2009, five new RA measures were included, for a total of six measures in the new RA Measures Group. The five new measures were developed in 2008 by the National Committee for Quality Assurance in collaboration with the ACR and the American Medical Association’s Physician Consortium for Performance Improvement and were subsequently adopted by Medicare.
The ACR recently conducted a survey of U.S. members about the issue of drug safety, sources of information, and related issues. The survey netted 454 responses.
Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies